NCT00338585View on ClinicalTrials.gov

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

PHASE3TerminatedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Arterial Occlusive Diseases
Interventions
DRUG

alfimeprase

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

Sponsors
All Listed Sponsors
lead

ARCA Biopharma, Inc.

INDUSTRY

NCT00338585 - Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery | Biotech Hunter | Biotech Hunter